ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation-Reference-Cited by-同舟云学术

ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation

Published:2009-06-04 Issue:1 Volume:10 Page:
ISSN:1471-2350
Container-title:BMC Medical Genetics
language:en
Short-container-title:BMC Med Genet

Author:

Kitsios Georgios,Zintzaras Elias

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1186/1471-2350-10-50.pdf

Reference87 articles.

1. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ, American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group: Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007, 115: 2878-2901. 10.1161/CIRCULATIONAHA.107.183679.

2. Zintzaras E, Kitsios G: Identification of chromosomal regions linked to premature myocardial infarction: a meta-analysis of whole-genome searches. J Hum Genet. 2006, 51: 1015-1021. 10.1007/s10038-006-0053-x.

3. Damani SB, Topol EJ: Future use of genomics in coronary artery disease. J Am Coll Cardiol. 2007, 50: 1933-1940. 10.1016/j.jacc.2007.07.062.

4. Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004, 109: 1101-1107. 10.1161/01.CIR.0000118498.35499.B2.

5. Johnson JA, Cavallari LH: Cardiovascular pharmacogenomics. Exp Physiol. 2005, 90: 283-289. 10.1113/expphysiol.2004.028506.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases;European Journal of Pharmacology;2024-10

2. Association between Angiotensin‐converting enzyme (ACE) insertion/deletion (I/D) polymorphism on the susceptibility to psoriasis and oxidative stress (OS) in a cohort of pediatric psoriatic patients in Sri Lanka: A cross sectional study;Health Science Reports;2024-09

3. Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience);Molecular Biology Reports;2023-06-16

4. Ace gene insertion/deletion polymorphism is associated with glioblastoma in an Iranian population: a case-control study;Siberian journal of oncology;2023-05-03

5. Association ofACE Gene Polymorphisms with In-Stent Restenosis by Stent Type (Biomime, Supraflex, Xience);2023-04-19